The therapeutic efficacy of CD4+ T cells could be attributed to their ability to produce proinflammatory chemo- and cytokines that recruit and activate CD8+ T cells and innate immune cells, such as macrophages, to the site of the infection [35,36]. This evidence concerns the gene CD8A and infection.